Avanos Medical, Inc. (AVNS)
Stock Price Chart
Key Info
| Market Cap | 2.06B |
| Revenue (ttm) | 719.60M |
| Net Income (ttm) | 13.90M |
| Shares Out | 47.83M |
| EPS (ttm) | 0.29 |
| PE Ratio | 148.24 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | November 23 |
| Last Price | $42.99 |
| Previous Close | $42.49 |
| Change ($) | 0.50 |
| Change (%) | 1.18% |
| Day's Open | 42.60 |
| Day's Range | 42.60 - 43.62 |
| Day's Volume | 245,478 |
| 52-Week Range | 19.46 - 44.85 |
More Stats
| Market Cap | 2.06B |
| Enterprise Value | 2.20B |
| Earnings Date (est) | Mar 2, 2021 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 47.83M |
| Float | 46.99M |
| EPS (basic) | 0.30 |
| EPS (diluted) | 0.29 |
| FCF / Share | -0.62 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 0.67% |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 1.97M |
| Short Ratio | 8.46 |
| Short % of Float | 4.18% |
| Beta | 1.01 |
| PE Ratio | 148.24 |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 2.86 |
| PB Ratio | 1.58 |
| Revenue | 719.60M |
| Operating Income | 6.40M |
| Net Income | 13.90M |
| Free Cash Flow | -29.70M |
| Net Cash | -140.20M |
| Net Cash / Share | -2.93 |
| Gross Margin | 55.89% |
| Operating Margin | 0.89% |
| Profit Margin | 1.90% |
| FCF Margin | -4.13% |
| ROA | 0.44% |
| ROE | 1.09% |
| ROIC | -0.30% |
Analyst Forecasts
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 698 | 652 | 612 | 566 | 509 | 1,672 | 1,678 | 1,684 | 1,660 |
| Revenue Growth | 6.94% | 6.65% | 8.02% | 11.24% | -69.56% | -0.32% | -0.39% | 1.45% | - |
| Gross Profit | 402 | 391 | 337 | 297 | 258 | 549 | 612 | 603 | 591 |
| Operating Income | -34.60 | 8.70 | -23.00 | -87.40 | -120 | 90.50 | 223 | 227 | 208 |
| Net Income | -45.90 | 57.50 | 79.30 | 39.80 | -426 | 27.10 | 155 | 153 | 142 |
| Shares Outstanding | 47.93 | 47.43 | 46.84 | 46.67 | 46.61 | 46.54 | 46.54 | - | - |
| Earnings Per Share | -0.96 | 1.22 | 1.69 | 0.85 | -9.15 | 0.58 | 3.32 | 3.28 | - |
| EPS Growth | - | -27.81% | 98.82% | - | - | -82.53% | 1.22% | - | - |
| Operating Cash Flow | -74.50 | -146 | 144 | 189 | 97.60 | 148 | 224 | 203 | 140 |
| Capital Expenditures | -50.60 | -49.10 | -43.10 | -25.90 | -62.60 | -70.70 | -48.70 | -40.30 | -35.80 |
| Free Cash Flow | -125 | -195 | 101 | 163 | 35.00 | 77.20 | 175 | 162 | 104 |
| Cash & Equivalents | 205 | 385 | 220 | 114 | 130 | 149 | 44.10 | 47.90 | - |
| Total Debt | 325 | 248 | 581 | 579 | 578 | 627 | 11.90 | 75.90 | - |
| Net Cash / Debt | -120 | 137 | -361 | -465 | -449 | -478 | 32.20 | -28.00 | - |
| Assets | 1,800 | 1,833 | 2,196 | 2,072 | 2,000 | 2,518 | 2,484 | 2,534 | - |
| Liabilities | 534 | 536 | 981 | 969 | 945 | 1,027 | 405 | 479 | - |
| Book Value | 1,265 | 1,297 | 1,215 | 1,103 | 1,055 | 1,491 | 2,079 | 2,056 | - |
Company Profile
Company Details
| Full Name | Avanos Medical, Inc. |
| Country | United States |
| Employees | 4,700 |
| CEO | Joseph F. Woody |
Stock Information
| Ticker Symbol | AVNS |
| Stock Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Medical Devices |
| Unique Identifier | NYSE: AVNS |
Description
Avanos Medical operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Its product portfolio includes digestive health products, including enteral feeding tubes and solutions; respiratory health products, such as closed airway suction systems and oral care kits; and acute pain products comprising surgical pain pumps, and cold and compression therapy systems, as well as interventional pain management solutions that include minimally invasive interventional pain therapies. The company sells its products under the MIC-KEY, CORPAK, NEOMED, BALLARD, MICROCUFF, ENDOCLEAR, ON-Q, AMBIT, GAME READY, and COOLIEF brand names. It markets its products directly to hospitals and other healthcare providers, and through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.